- Home
- APWC vs ESLA Comparison
APWC vs ESLA Comparison
Compare APWC & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APWC | ESLA |
|---|---|---|
| Founded | 1996 | 2021 |
| Country | Taiwan | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.3M | 69.5M |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | APWC | ESLA |
|---|---|---|
| Price | $1.42 | $1.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 6.8K | ★ 31.1K |
| Earning Date | 04-29-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.60 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.27 | $0.78 |
| 52 Week High | $2.34 | $3.15 |
Technical Indicators
Market Signals| Indicator | APWC | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 46.20 | 36.55 |
| Support Level | $1.28 | $0.99 |
| Resistance Level | $1.47 | $1.35 |
| Average True Range (ATR) | 0.06 | 0.13 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 12.50 | 8.70 |
Price Performance
Historical ComparisonAbout APWC Asia Pacific Wire & Cable Corporation Ltd. (Bermuda)
Asia Pacific Wire & Cable Corp Ltd is a holding company. It is principally engaged in the manufacture and distribution of enameled wire, power cable, and telecommunications products in Thailand, Singapore, Australia, PRC, Hong Kong and certain other markets in the Asia Pacific region. It also provides project engineering services in the supply, delivery and installation of power cables (SDI). Some of the company's products are Bare wires, Power cables, Communication cables, Electronic wires & cables, and Enamelled wires. The company's geographical segments are North Asia, Thailand, and Rest of the World.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.